undamentalytics Newsletter
Sign in

Inogen Inc balance sheet

At the end of fiscal 2025, Inogen Inc had total assets of $299m, total liabilities of $106m and shareholders' equity of $192m. It held $104m in cash against $0 of debt: net cash of $104m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents151457669314319719821223618712511410487
Receivables—1019203131373430246342303946
Inventory—4891419273625323422252629
Total current assets—3393115162228315292306329305207185198194
Goodwill—————22333333331091110
Total assets—82140161214275376447462490405326296299286
Accounts payable——77610141613101813172025
Deferred revenue (current)—12224—————————
Total current liabilities—1919222334475057626572776471
Short-term debt—500———————————
Long-term debt—500———————————
Total debt0111000000000000
Total liabilities—262227324865103112119108121122106111
Shareholders' equity−81−62118134182227310345350370297205174192175
Non-controlling interests and other (assets − liabilities − equity)—119—————————————
Net debt (negative = net cash)−15−3−56−66−93−143−197−198−212−236−187−125−114−104−87
Shares outstanding—2m19m20m20m21m22m22m22m23m23m23m24m27m27m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: INGN vs TCMDINGN vs STAAINGN vs INMDINGN vs PRCT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Inogen Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inogen Inc.